Skip to main content
Premium Trial:

Request an Annual Quote

Millipore To Open Training Facility in Singapore Next Year

NEW YORK (GenomeWeb News) – Millipore plans to open a new applications and training facility in Singapore, the company announced yesterday.
 
The state-of-the-art facility is intended to cater to biotech customers operating in Asia. Millipore President and CEO Martin Madaus announced the move during his visit to Singapore, Beijing, and Tokyo for the Bioforum Asia conference.
 
The facility, to be located in Singapore’s Science Park, is expected to open early in 2009. The company said it will provide technical support for biopharmaceutical manufacturing, including tools for investigating, exploring, and optimizing separation, purification, and monitoring.
 
“Many of our large multinational customers and local manufacturers have made significant investments in Asia and this new facility continues and enhances the local support that we have provided over the past 25 years we have been in Singapore,” Madaus said in a statement.

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.